Yamada A, Brown L E, Webster R G
Virology. 1984 Oct 30;138(2):276-86. doi: 10.1016/0042-6822(84)90351-9.
Antigenic analysis of human and avian H2 influenza viruses were done with monoclonal antibodies to the HA molecules in hemagglutination inhibition (HI) assays. These studies revealed that the receptor-binding specificity of the hemagglutinin can markedly influence the antigenic analysis obtained with monoclonal antibodies in HI tests. Influenza viruses that are sensitive or resistant to inhibition by horse serum inhibitors showed marked differences in their reactivity with monoclonal antibodies to the hemagglutinin. This was apparent with the A/RI/5+/57 and A/RI/5-/57 strains of H2N2 viruses isolated by Choppin and Tamm (1960a), half of the panel of different monoclonal antibodies failed to inhibit hemagglutination of the RI/5- variant, whereas all of the 18 monoclonal antibodies inhibited RI/5+. These findings have important implications in the antigenic analysis of influenza viruses where HI assays are conventionally used to determine the extent of antigenic drift in nature. Antigenic differences were detectable between different human H2 influenza virus isolates from 1957 that were sensitive to inhibition by horse serum, indicating that minor antigenic variation occurs within the first year of appearance of the new subtype. Minor antigenic variation continued in the H2 viruses until 1961, but by 1962 antigenically distinguishable variants that could be discriminated with both monoclonal antibodies and postinfection ferret antisera predominated. Analysis of avian H2 influenza viruses with a panel of monoclonal antibodies indicated that antigenic variation occurs and that multiple different variants cocirculate in the population. There was no progressive antigenic change in the avian H2 influenza viruses with time, as was found with the human H2N2 strains. Topographical mapping of the H2 hemagglutinin by selection of antigenic variants with monoclonal antibodies and analysis of their reactivity patterns by HI showed overlap between the epitopes examined. These results may reflect restriction in the antibody repertoire of the mice used in preparation of the monoclonal antibodies or that the H2 hemagglutinin does not have such discrete nonoverlapping antigenic regions found in the early H3 influenza virus.
利用针对血凝素(HA)分子的单克隆抗体,在血凝抑制(HI)试验中对人源和禽源H2流感病毒进行了抗原分析。这些研究表明,血凝素的受体结合特异性可显著影响HI试验中用单克隆抗体获得的抗原分析结果。对马血清抑制剂敏感或耐药的流感病毒,在与针对血凝素的单克隆抗体反应性方面表现出明显差异。这在Choppin和Tamm(1960a)分离的H2N2病毒的A/RI/5+/57和A/RI/5-/57毒株中很明显,不同单克隆抗体组中有一半未能抑制RI/5-变异株的血凝,而所有18种单克隆抗体均能抑制RI/5+。这些发现对流感病毒的抗原分析具有重要意义,在流感病毒抗原分析中,传统上使用HI试验来确定自然界中抗原漂移的程度。1957年分离的不同人源H2流感病毒株之间可检测到抗原差异,这些病毒株对马血清抑制敏感,这表明新亚型出现后的第一年就发生了微小的抗原变异。H2病毒中的微小抗原变异一直持续到1961年,但到1962年,用单克隆抗体和感染后雪貂抗血清均可区分的抗原性可区分变异株占主导地位。用一组单克隆抗体分析禽源H2流感病毒表明,存在抗原变异,且多种不同变异株在群体中共同传播。与人类H2N2毒株不同,禽源H2流感病毒并未随时间发生渐进性抗原变化。通过选择具有抗原变异的单克隆抗体对H2血凝素进行拓扑绘图,并通过HI分析其反应模式,结果显示所检测的表位之间存在重叠。这些结果可能反映了制备单克隆抗体所用小鼠抗体库的限制,或者H2血凝素没有早期H3流感病毒中发现的那种离散的非重叠抗原区域。